Table 3. All-cause mortality during the 52 and 104 week follow-up periods.
VT+C | C-alone | |
---|---|---|
Arrhythmic event | 1 | 0 |
Bradycardia | 1 | 0 |
Lung cancer | 0 | 2 |
Non ST segment Myocardial Infarction | 2 | 4 |
Respiratory failure/COPD | 2 | 0 |
Stroke | 0 | 1 |
Total deaths ≤ 12 months | 6 | 7 |
Charleston: age unadjusted (mean ± SD) | 3.29 ± 2.43 | 2.43 ± 1.62 |
Charleston: age adjusted (mean ± SD) | 5.14 + 2.61 | 3.86 ± 2.12 |
Lung cancer | 1 | 2 |
Respiratory failure/COPD | 1 | 2 |
Peripheral vascular disease | 2 | 1 |
Total deaths between >12 and ≤ 24 months | 4 | 5 |
Charleston: age unadjusted (mean ± SD) | 4.25 ± 3.20 | 4.40 ± 4.28 |
Charleston: age adjusted (mean ± SD) | 5.50 + 3.70 | 5.80 ± 4.44 |
Number of events per arm; total sample size in each arm n = 196